Oncology Clinical Trials Information for Clinicians
The NCCN Oncology Research Program (ORP) has received millions of dollars in research grants from major pharmaceutical companies to support investigator-initiated trials at NCCN Member Institutions that explore new avenues of clinical investigation to answer important scientific questions. Studies evaluate innovative combinations and sequencing regimens of drugs, mechanisms of action of specific agents, drug resistance, or are directed toward exploring extended uses for specific agents.